Click on image to view larger version.

Figure 2 Kaplan-Meier Estimates of Primary End Point With Perindopril and Placebo According to Baseline eGFR

Kaplan-Meier estimates of the primary end point with perindopril and placebo for different estimated glomerular filtration rates (eGFR) during follow-up (days). The black line corresponds to patients with an eGFR <75 using placebo, and the dotted black line corresponds to patients with an eGFR <75 using perindopril. The red line corresponds to patients with an eGFR 75 using placebo, and the dotted red line corresponds to patients with an eGFR 75 using perindopril. The X-axis represents the follow-up time in days. The Y-axis represents the risk of the primary end point. AMI = acute myocardial infarction.